WILMINGTON, Del.--(BUSINESS WIRE)--Global Indemnity Group, LLC (NYSE:GBLI) (“GBLI”) announced today that its Board of Directors approved a dividend rate of $0.35 per common share payable on March 28, 2024 to all shareholders of record as of the close of business on March 21, 2024, a 40% increase over the prior quarterly dividend rate of $0.25 per common share. “The increase in GBLI’s dividend reflects the company’s ongoing strong financial performance, capital and reserve positions, liquidity, and balanc ...

[PART I – FINANCIAL INFORMATION](index=3&type=section&id=PART%20I%20%E2%80%93%20FINANCIAL%20INFORMATION) This section presents the company's unaudited consolidated financial statements, management's analysis of financial condition, market risk disclosures, and internal controls [Item 1. Financial Statements](index=3&type=section&id=Item%201.%20Financial%20Statements) This section presents Global Indemnity Group's unaudited consolidated financial statements for Q3 and nine months ended September 30, 2023 [Consolidated Balance Sheets](index=3&type=section&id=Consolidated%20Balance%20Sheets) This section details the company's financial position, presenting assets, liabilities, and shareholders' equity for September 30, 2023, and December 31, 2022 Consolidated Balance Sheet Highlights (Unaudited) | Metric | September 30, 2023 (in millions) | December 31, 2022 (in millions) | | :--- | :--- | :--- | | **Total Investments** | $1,340.9 | $1,303.9 | | **Total Assets** | $1,767.8 | $1,800.8 | | **Total Liabilities** | $1,137.2 | $1,174.5 | | **Total Shareholders' Equity** | $630.7 | $626.2 | - Total assets decreased slightly to **$1.77 billion** from **$1.80 billion** at year-end 2022, while total shareholders' equity increased to **$630.7 million** from **$626.2 million** over the same period[8](index=8&type=chunk) [Consolidated Statements of Operations](index=4&type=section&id=Consolidated%20Statements%20of%20Operations) This section details the company's financial performance over specific periods, presenting revenues, expenses, and net income or loss Key Operating Results (Unaudited) | Metric | Q3 2023 (in millions) | Q3 2022 (in millions) | Nine Months 2023 (in millions) | Nine Months 2022 (in millions) | | :--- | :--- | :--- | :--- | :--- | | Gross Written Premiums | $98.9 | $175.8 | $332.0 | $563.6 | | Net Earned Premiums | $111.7 | $153.6 | $380.9 | $458.2 | | Total Revenues | $126.1 | $194.6 | $418.9 | $472.9 | | Net Income (Loss) | $7.7 | $23.7 | $19.5 | $(3.2) | | Diluted EPS | $0.55 | $1.60 | $1.39 | $(0.24) | - Net income for the nine months ended September 30, 2023, was **$19.5 million**, a significant turnaround from a net loss of **$3.2 million** in the same period of 2022; however, Q3 2023 net income of **$7.7 million** was lower than Q3 2022's **$23.7 million**, which was boosted by other income[10](index=10&type=chunk) [Consolidated Statements of Cash Flows](index=7&type=section&id=Consolidated%20Statements%20of%20Cash%20Flows) This section outlines the cash inflows and outflows from operating, investing, and financing activities for the specified periods Cash Flow Summary (Unaudited) | Cash Flow Activity | Nine Months Ended Sep 30, 2023 (in millions) | Nine Months Ended Sep 30, 2022 (in millions) | | :--- | :--- | :--- | | Net cash provided by operating activities | $36.8 | $41.7 | | Net cash provided by (used for) investing activities | $(8.6) | $37.0 | | Net cash used for financing activities | $(20.5) | $(138.1) | | **Net change in cash and cash equivalents** | **$7.6** | **$(59.4)** | [Notes to Consolidated Financial Statements](index=8&type=section&id=Notes%20to%20Consolidated%20Financial%20Statements) This section provides detailed explanations and disclosures supporting the consolidated financial statements, including accounting policies and significant transactions - The Company completed a restructuring of its insurance operations in Q1 2023, exiting four brokerage divisions to focus on core Package Specialty and Targeted Specialty products; total restructuring costs were **$5.5 million**, with **$2.1 million** incurred in the first nine months of 2023[23](index=23&type=chunk)[24](index=24&type=chunk) - On August 8, 2022, the Company sold the renewal rights for its Farm, Ranch & Stable business for **$30.0 million**, recognized as other income; related impairments and expenses totaled **$9.2 million**[26](index=26&type=chunk)[27](index=27&type=chunk)[28](index=28&type=chunk) - The Company's investment portfolio, primarily fixed maturities, was valued at **$1.29 billion** at fair value as of September 30, 2023; the portfolio's book yield increased from approximately **2.2%** at December 31, 2021, to **4.0%** at September 30, 2023[29](index=29&type=chunk)[45](index=45&type=chunk) - For the nine months ended September 30, 2023, prior accident year loss reserve adjustments netted to zero, comprising a **$21.0 million** increase for Commercial Specialty, offset by decreases of **$1.7 million** for Reinsurance Operations and **$19.3 million** for Exited Lines[94](index=94&type=chunk)[95](index=95&type=chunk)[96](index=96&type=chunk)[97](index=97&type=chunk) - The Company's share repurchase authorization was increased to **$135 million**, expiring on December 31, 2027; during the nine months ended September 30, 2023, the company purchased **468,860 Class A common shares**[99](index=99&type=chunk)[101](index=101&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=35&type=section&id=Item%202.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management analyzes Q3 and nine-month 2023 financial results, detailing strategic restructuring impacts, investment income, segment performance, liquidity, and capital [Financial Highlights](index=35&type=section&id=Financial%20Highlights) This section summarizes key financial metrics and performance indicators for the third quarter of 2023 Q3 2023 Financial Highlights | Metric | Value | | :--- | :--- | | Net Income | $7.7 million | | Diluted EPS | $0.55 | | Net Earned Premium | $111.7 million | | Continuing Lines Accident Year Combined Ratio | 97.8% | | Net Investment Income | $14.2 million | | Book Value Per Common Share | $46.27 | [Results of Operations](index=35&type=section&id=Results%20of%20Operations) This section provides a detailed analysis of the company's revenues, expenses, and profitability across its business segments - Gross written premiums decreased by **43.7%** in Q3 2023 and **41.1%** in the first nine months of 2023, driven by restructuring, business exits, and non-renewal of treaties[149](index=149&type=chunk)[151](index=151&type=chunk) - Net investment income increased significantly by **69.3%** in Q3 2023 and **133.1%** in the first nine months of 2023, due to investment portfolio repositioning and a higher book yield of **4.0%**[144](index=144&type=chunk)[145](index=145&type=chunk)[146](index=146&type=chunk) - The Commercial Specialty segment incurred an underwriting loss of **$12.3 million** in Q3 2023, primarily due to a **$14.5 million** strengthening of prior accident year reserves and **$2.5 million** in Maui fire losses[160](index=160&type=chunk)[161](index=161&type=chunk) - Corporate and other operating expenses decreased to **$5.3 million** in Q3 2023 from **$14.1 million** in Q3 2022, mainly due to prior-year impairments and expenses from the Farm, Ranch & Stable renewal rights sale[198](index=198&type=chunk) [Liquidity and Capital Resources](index=50&type=section&id=Liquidity%20and%20Capital%20Resources) This section assesses the company's ability to meet its financial obligations and fund operations, including cash flow, share repurchases, and restructuring impacts - Net cash provided by operating activities was **$36.8 million** for the first nine months of 2023, a decrease from **$41.7 million** in the same period of 2022, primarily due to lower net premiums collected[215](index=215&type=chunk) - The company's share buyback authorization increased to **$135 million**; **450,000 shares** were repurchased for approximately **$12.1 million** in the first nine months of 2023, increasing book value per share by **$0.60**[216](index=216&type=chunk)[217](index=217&type=chunk) - The Q1 2023 restructuring incurred total costs of **$5.5 million** and is expected to generate recurring annual expense savings of **$16.0 million**[219](index=219&type=chunk)[220](index=220&type=chunk) [Quantitative and Qualitative Disclosures about Market Risk](index=52&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20about%20Market%20Risk) The company's investment grade fixed income portfolio maintains an **A+ average rating** and **1.2-year duration**, increasing U.S. Treasury allocation amid Q3 market volatility - The company's investment grade fixed income portfolio maintains a high quality with an **A+ average rating** and a short duration of **1.2 years** as of September 30, 2023[231](index=231&type=chunk) - During Q3 2023, the portfolio's allocation to U.S. Treasury securities increased, while exposure to investment grade credit decreased, funded by cash inflows, maturities, and paydowns[231](index=231&type=chunk) [Controls and Procedures](index=52&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded the company's disclosure controls and procedures were effective as of September 30, 2023, with no material internal control changes during the quarter - The CEO and CFO concluded that as of September 30, 2023, the company's disclosure controls and procedures were effective[233](index=233&type=chunk) - There were no material changes in the company's internal controls over financial reporting during the third quarter of 2023[234](index=234&type=chunk) [PART II – OTHER INFORMATION](index=53&type=section&id=PART%20II%20%E2%80%93%20OTHER%20INFORMATION) This section provides disclosures on legal proceedings, risk factors, equity security sales, and a list of filed exhibits [Legal Proceedings](index=53&type=section&id=Item%201.%20Legal%20Proceedings) The company is involved in various legal proceedings, but management does not anticipate any material adverse effect on its business or financial condition - The company does not expect any currently pending legal proceedings to have a material adverse effect on its business or financial condition[236](index=236&type=chunk) [Risk Factors](index=53&type=section&id=Item%201A.%20Risk%20Factors) No material changes have occurred to the risk factors previously disclosed in the company's 2022 Annual Report on Form 10-K - The risk factors identified in the company's 2022 Annual Report on Form 10-K have not materially changed[238](index=238&type=chunk) [Unregistered Sales of Equity Securities and Use of Proceeds](index=53&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) During the nine months ended September 30, 2023, **18,860 Class A common shares** were surrendered for tax liabilities, and **450,000 shares** were repurchased, with no Q3 repurchases - No shares were repurchased by the company during the quarter ended September 30, 2023[240](index=240&type=chunk) - For the nine months ended September 30, 2023, the company repurchased **450,000 shares** under its repurchase program[240](index=240&type=chunk) [Exhibits](index=54&type=section&id=Item%206.%20Exhibits) This section lists exhibits filed with the Form 10-Q, including CEO and CFO certifications and Inline XBRL documents - Exhibits filed include CEO and CFO certifications under Sections 302 and 906 of the Sarbanes-Oxley Act, as well as XBRL data files[244](index=244&type=chunk)

Global Indemnity Group, LLC (NYSE:GBLI) Q2 2023 Results Conference Call August 8, 2023 11:00 AM ET Company Participants Steve Ries - IR Jay Brown - CEO Tom McGeehan - CFO Conference Call Participants Ross Haberman - RLH Investment Tom Kerr - Zacks Investments Guy Baron - Springview Andrew Vindigni - General American Investors Company Operator Hello and welcome to the GBLI 2Q 2023 Earnings Call. [Operator Instructions] I will now turn the conference over to Mr. Steve Ries. Please go ahead. Steve Ries Thank y ...

[PART I – FINANCIAL INFORMATION](index=3&type=section&id=PART%20I%20%E2%80%93%20FINANCIAL%20INFORMATION) This section details the company's financial performance, condition, market risks, and internal controls for the reporting period [Financial Statements](index=3&type=section&id=Item%201.%20Financial%20Statements) The unaudited consolidated financial statements show a turnaround to net income in Q2 2023 and improved financial position [Consolidated Balance Sheets](index=3&type=section&id=Consolidated%20Balance%20Sheets) | Metric | June 30, 2023 (Unaudited) | December 31, 2022 | | :--- | :--- | :--- | | **Total Investments** | $1,320,041 thousand | $1,303,894 thousand | | **Total Assets** | $1,774,002 thousand | $1,800,775 thousand | | **Total Liabilities** | $1,147,594 thousand | $1,174,546 thousand | | **Total Shareholders' Equity** | $626,408 thousand | $626,229 thousand | [Consolidated Statements of Operations](index=4&type=section&id=Consolidated%20Statements%20of%20Operations) | Metric | Q2 2023 (Unaudited) | Q2 2022 (Unaudited) | | :--- | :--- | :--- | | **Net Earned Premiums** | $129,156 thousand | $155,749 thousand | | **Total Revenues** | $141,893 thousand | $147,860 thousand | | **Net Income (Loss)** | $9,337 thousand | $(12,162) thousand | | **Diluted EPS** | $0.67 | $(0.84) | | Metric | Six Months 2023 (Unaudited) | Six Months 2022 (Unaudited) | | :--- | :--- | :--- | | **Net Earned Premiums** | $269,228 thousand | $304,572 thousand | | **Total Revenues** | $292,807 thousand | $278,316 thousand | | **Net Income (Loss)** | $11,831 thousand | $(26,935) thousand | | **Diluted EPS** | $0.84 | $(1.87) | [Consolidated Statements of Comprehensive Income (Loss)](index=5&type=section&id=Consolidated%20Statements%20of%20Comprehensive%20Income%20(Loss)) - Comprehensive income for Q2 2023 was **$6.8 million**, a significant improvement from a comprehensive loss of **$26.0 million** in Q2 2022. For the six-month period, comprehensive income was **$17.7 million** in 2023, compared to a loss of **$60.0 million** in 2022, mainly due to smaller unrealized losses on investments[14](index=14&type=chunk) [Consolidated Statements of Changes in Shareholders' Equity](index=6&type=section&id=Consolidated%20Statements%20of%20Changes%20in%20Shareholders'%20Equity) - Total shareholders' equity remained stable at **$626.4 million** as of June 30, 2023, compared to **$626.2 million** at year-end 2022. The company repurchased **468,860 Class A common shares** for **$12.7 million** during the first six months of 2023 and paid distributions of **$6.8 million** to common shareholders[16](index=16&type=chunk) [Consolidated Statements of Cash Flows](index=7&type=section&id=Consolidated%20Statements%20of%20Cash%20Flows) | Cash Flow Activity (Six Months Ended June 30) | 2023 (Unaudited) | 2022 (Unaudited) | | :--- | :--- | :--- | | **Net cash provided by operating activities** | $14,171 thousand | $18,459 thousand | | **Net cash provided by (used for) investing activities** | $12,804 thousand | $(137,889) thousand | | **Net cash used for financing activities** | $(20,374) thousand | $(7,679) thousand | | **Net change in cash and cash equivalents** | $6,601 thousand | $(18,436) thousand | [Notes to Consolidated Financial Statements (Unaudited)](index=8&type=section&id=Notes%20to%20Consolidated%20Financial%20Statements%20(Unaudited)) - The company restructured its insurance operations, exiting four brokerage divisions (Professional Liability, Excess Casualty, Environmental, and Middle Market Property) to focus on core Package Specialty and Targeted Specialty products. The restructuring was completed in Q1 2023[24](index=24&type=chunk) | Restructuring Costs (in thousands) | 2022 | 2023 (6 months) | Total | | :--- | :--- | :--- | :--- | | **Charges Incurred** | $3,447 | $2,121 | $5,568 | - On June 8, 2023, the Board of Directors increased the share buyback authorization from **$60 million** to **$135 million**, with the program set to expire on December 31, 2027[94](index=94&type=chunk) - The company manages its business through three segments: Commercial Specialty, Reinsurance Operations, and Exited Lines. Segment results for 2022 have been revised to reflect the restructuring and reclassification of certain treaties[125](index=125&type=chunk)[126](index=126&type=chunk) [Management's Discussion and Analysis of Financial Condition and Results of Operations](index=35&type=section&id=Item%202.%20Management's%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses improved Q2 2023 net income, driven by strategic actions, better underwriting, and increased investment income, while maintaining strong liquidity [Financial Highlights](index=35&type=section&id=Financial%20Highlights) - Key financial highlights for Q2 2023 include: - Net income of **$9.3 million**, or **$0.67 per diluted share** - Continuing Lines accident year combined ratio of **94.9%**, an improvement from **96.8%** in Q2 2022 - Net investment income of **$13.2 million**, with a book yield on the fixed maturities portfolio of **3.8%** - Total capital returned to shareholders of **$9.1 million** in Q2 2023 (**$5.6 million** in repurchases, **$3.5 million** in distributions) - Book value per common share of **$46.03**[137](index=137&type=chunk)[138](index=138&type=chunk) [Results of Operations](index=35&type=section&id=Results%20of%20Operations) | Metric (Q2) | 2023 | 2022 | % Change | | :--- | :--- | :--- | :--- | | **Gross written premiums** | $110.1M | $196.8M | (44.1%) | | **Net earned premiums** | $129.2M | $155.7M | (17.1%) | | **Underwriting income** | $4.3M | $2.1M | 101.9% | | **Net investment income** | $13.2M | $1.9M | NM | | **Net income (loss)** | $9.3M | $(12.2)M | (176.8%) | - The decrease in gross written premiums for Q2 and the first six months of 2023 is driven by reductions in both Continuing Lines (due to non-renewal of a casualty treaty and underperforming business) and Exited Lines[146](index=146&type=chunk) - The company's net premium retention increased to **96.3%** in Q2 2023 from **84.9%** in Q2 2022, primarily because the Exited Lines, which had lower retention, now constitute a much smaller portion of the business[148](index=148&type=chunk) [Underwriting Results by Segment](index=40&type=section&id=Underwriting%20Results%20by%20Segment) - **Commercial Specialty:** The accident year combined ratio improved to **93.7%** in Q2 2023 from **96.4%** in Q2 2022, reflecting actions taken to improve profitability. However, the calendar year combined ratio increased to **99.2%** due to adverse prior year reserve development[155](index=155&type=chunk)[156](index=156&type=chunk) - **Reinsurance Operations:** The combined ratio deteriorated to **102.3%** in Q2 2023 from **95.4%** in Q2 2022, driven by a higher loss ratio which included adverse prior year development. The company is strategically reducing writings in this segment[147](index=147&type=chunk)[169](index=169&type=chunk) - **Exited Lines:** This segment produced an underwriting income of **$3.9 million** in Q2 2023, compared to a loss of **$5.6 million** in Q2 2022, largely due to significant favorable prior year reserve development of **$5.9 million**[178](index=178&type=chunk) [Liquidity and Capital Resources](index=50&type=section&id=Liquidity%20and%20Capital%20Resources) - The company's primary sources of funds are underwriting operations and investment income, used to pay claims, operating expenses, and shareholder distributions. As a holding company, Global Indemnity Group, LLC relies on dividends from its subsidiaries[207](index=207&type=chunk)[208](index=208&type=chunk) - Net cash from operations was **$14.2 million** for the first six months of 2023, a decrease from **$18.5 million** in the prior year period[213](index=213&type=chunk) - Under its expanded **$135 million** share repurchase authorization, the company repurchased **450,000 shares** for **$12.1 million** in the first six months of 2023. Since the program's inception in October 2022, total repurchases amount to **$34.0 million**[214](index=214&type=chunk)[215](index=215&type=chunk)[216](index=216&type=chunk) - The restructuring completed in Q1 2023 incurred total costs of **$5.5 million** and is anticipated to generate recurring annual expense savings of **$16.0 million**[217](index=217&type=chunk) [Quantitative and Qualitative Disclosures about Market Risk](index=53&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20about%20Market%20Risk) The company's investment portfolio maintains an 'A' average rating and short duration amidst market volatility and yield curve inversion - The company's investment grade fixed income portfolio has an **'A' average rating** and a duration of **1.3 years** as of June 30, 2023[227](index=227&type=chunk) - During Q2 2023, the portfolio's allocation shifted towards U.S. Treasury securities, funded by cash inflows and sales of other securities, reducing exposure to investment grade credit and Commercial Mortgage-Backed Securities (CMBS)[227](index=227&type=chunk) [Controls and Procedures](index=53&type=section&id=Item%204.%20Controls%20and%20Procedures) Management confirmed the effectiveness of disclosure controls and procedures with no material changes to internal controls during the quarter - The CEO and CFO concluded that as of June 30, 2023, the company's disclosure controls and procedures were effective[229](index=229&type=chunk) - No material changes were made to the company's internal controls over financial reporting during the quarter ended June 30, 2023[230](index=230&type=chunk) [PART II – OTHER INFORMATION](index=54&type=section&id=PART%20II%20%E2%80%93%20OTHER%20INFORMATION) This section addresses legal matters, risk factors, equity transactions, and required regulatory exhibits [Legal Proceedings](index=54&type=section&id=Item%201.%20Legal%20Proceedings) The company is involved in routine legal proceedings, not expecting a material adverse effect on its financial condition - The company does not expect any currently pending legal proceedings to have a material adverse effect on its business, results of operations, cash flows, or financial condition[233](index=233&type=chunk) [Risk Factors](index=54&type=section&id=Item%201A.%20Risk%20Factors) There have been no material changes to the risk factors previously disclosed in the company's 2022 Annual Report on Form 10-K, filed on March 15, 2023 - The risk factors identified in the Company's 2022 Annual Report on Form 10-K have not materially changed[235](index=235&type=chunk) [Unregistered Sales of Equity Securities and Use of Proceeds](index=54&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) The company repurchased Class A common shares from third parties and received shares from employees for tax liabilities in Q2 2023 - In Q2 2023, the company repurchased **200,000 Class A common shares** under its repurchase program[237](index=237&type=chunk) - For the six months ended June 30, 2023, a total of **450,000 shares** were repurchased from third parties, and **18,860 shares** were surrendered by employees for tax payments[236](index=236&type=chunk)[237](index=237&type=chunk) [Exhibits](index=55&type=section&id=Item%206.%20Exhibits) This section lists the exhibits filed with the Form 10-Q, including CEO and CFO certifications as required by the Sarbanes-Oxley Act of 2002 and Inline XBRL data files

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2023 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to 001-34809 Commission File Number GLOBAL INDEMNITY GROUP, LLC (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or o ...

f UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from ___________ to ___________ 001-34809 Commission File Number GLOBAL INDEMNITY GROUP, LLC (Exact name of registrant as specified in its charter) (State or other jurisdiction ...

Global Indemnity Group, LLC (NYSE:GBLI) Q4 2022 Earnings Conference Call March 9, 2023 11:00 AM ET Company Participants Stephen Ries - Head of Investor Relations Joseph Brown - Chief Executive Officer Thomas McGeehan - Chief Financial Officer Conference Call Participants Thomas Kerr - Zacks Investment Research, Inc. Operator Good morning, and welcome to Global Indemnity Group 2022 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' remarks, there ...

Global Indemnity Group, LLC (NYSE:GBLI) Q3 2022 Earnings Conference Call November 8, 2022 11:00 AM ET Company Participants Stephen Ries - Head of Investor Relations Joseph Brown - Chief Executive Officer Thomas McGeehan - Chief Financial Officer Jonathan Oltman - President of Insurance Operations Conference Call Participants Anthony Mottolese - Dowling & Partners Securities, LLC Thomas Kerr - Zacks Investment Research, Inc. Operator Good day, and welcome to the Global Indemnity Group, LLC Third Quarter 2022 ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Transition Period from to 001-34809 Commission File Number GLOBAL INDEMNITY GROUP, LLC (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation ...

Global Indemnity Group, LLC (NYSE:GBLI) Q2 2022 Earnings Conference Call August 9, 2022 11:00 AM ET Company Participants Stephen Ries - Head-Investor Relations David Charlton - Chief Executive Officer Thomas McGeehan - Chief Financial Officer Jonathan Oltman - President of Insurance Operations Conference Call Participants Anthony Mottolese - Dowling & Partners Thomas Kerr - Zacks Investment Research Operator Good day, and welcome to the Global Indemnity Group LLC's Second Quarter 2022 Earnings Conference Ca ...